MariMed Inc. (MRMD)
|Net Income (ttm)||2.14M|
|Trading Day||April 16|
|Day's Range||0.6300 - 0.6950|
|52-Week Range||0.1285 - 1.0200|
Cannabis company MariMed Inc. (OTCQX:MRMD) closed a $46 million financing facility Tuesday with Hadron Healthcare Fund. Beacon Securities Ltd.
While cannabis legalization may not be a slam-dunk, that hasn't stopped investors from sending marijuana penny stocks to higher highs. The post 4 Marijuana Penny Stocks Winning Under Democratic Leadersh...
MariMed prints positive net earnings and is set to continue this trend; With #1 selling edibles products, MariMed could grow revenues beyond projections as more dispensaries take on new products.
NORWOOD, Mass., Jan. 4, 2021 /PRNewswire/ -- MariMed Inc. (MRMD:OTCQX) (the "Company" or "MariMed"), a leading multi-state cannabis operator based in Massachusetts, is pleased to announce that Chief Exe...
Financial leverage measures the degree to which a company uses debt to fund its operations. Leverage can magnify gains as well as losses.
MariMed Introduces World-Famous ‘Tikun Olam' Genetics, Flower and Products into Massachusetts Market
NORWOOD, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- International cannabis pioneer Tikun Olam's award-winning heirloom cannabis products will be available for purchase in Massachusetts this week. MariMed,...
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. It offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and drink powder mixes under the brand Kalm Fusion; and natural fruit chews under the Betty's Eddies brand, and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilit... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |